111 results
10-K
2023 FY
EX-10.28
OCX
Oncocyte Corporation
Annual report
15 Apr 24
9:55pm
10-K
2023 FY
EX-10.29
OCX
Oncocyte Corporation
Annual report
15 Apr 24
9:55pm
10-K
2023 FY
EX-10.30
OCX
Oncocyte Corporation
Annual report
15 Apr 24
9:55pm
8-K
EX-10.2
OCX
Oncocyte Corporation
12 Apr 24
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
6:04am
8-K
EX-10.1
OCX
Oncocyte Corporation
12 Apr 24
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
6:04am
8-K
EX-10.1
zd32j5olnrtenkyjwf
14 Jul 23
Departure of Directors or Certain Officers
6:03am
8-K
EX-10.1
0cd3s7l oir55gafdjf
8 Jun 23
Departure of Directors or Certain Officers
6:29pm
8-K
EX-10.1
u14y0i0 4re9l
6 Apr 23
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-10.1
jyhy8
13 Feb 23
Entry into a Material Definitive Agreement
4:07pm
8-K
EX-10.1
7ru3wlib
3 Feb 23
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
7n1pfryqxfe2llx8rz4
21 Dec 22
Oncocyte Announces Initiatives to Focus Corporate Strategy
6:05am
8-K
EX-10.2
bppisv39jf5 kdjkm
21 Dec 22
Oncocyte Announces Initiatives to Focus Corporate Strategy
6:05am
8-K
EX-10.3
gh66vl4
21 Dec 22
Oncocyte Announces Initiatives to Focus Corporate Strategy
6:05am
8-K
EX-10.3
kmowoiy7sfmyt1m
5 Dec 22
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
7awusnp13dyibg d565
5 Dec 22
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.4
bp49v0
5 Dec 22
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.2
y7t6ykj34wpxbbjk 1r
5 Dec 22
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
8hxb9cw5ptf3tssh
13 Apr 22
Oncocyte Corporation Announces Pricing of Registered Direct Offering of 11,765 Shares of Series A Convertible Preferred Stock
5:09pm